A5054183389- Lung Cancer Treatments and Mutations
- BRCA gene mutations in cancer
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Paraquat toxicity studies and treatments
- Heme Oxygenase-1 and Carbon Monoxide
- Business, Innovation, and Economy
- Opioid Use Disorder Treatment
- Plant-based Medicinal Research
- Gastric Cancer Management and Outcomes
- Economic and Financial Impacts of Cancer
- Alcoholism and Thiamine Deficiency
- Viral-associated cancers and disorders
- Lymphoma Diagnosis and Treatment
- Electroconvulsive Therapy Studies
- Meta-analysis and systematic reviews
- Forensic Toxicology and Drug Analysis
- Poisoning and overdose treatments
- Cancer Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Health and Medical Education
- CAR-T cell therapy research
- Neurological and metabolic disorders
- Breast Cancer Treatment Studies
Sociedade Brasileira de Oncologia Clínica
2023
Universidad de Antioquia
2021-2022
Departamento de Epidemiología
2021
Hospital Universitario de San Vicente Fundación
2021
Purpose: This is the first report of an institutional-based cancer registry in Clínica de Oncología Astorga, Medellín, Colombia. It was created to produce local information on socio-demographic and clinical characteristics, therapies, survival outcomes patients with most frequent tumors institution. Methods: All consecutive cancers breast (BC), prostate (PC), lung (LC), colorectal (CRC), ovarian, stomach, pancreas, cervical, melanoma, diagnosed after January 1/2019, treated at institution...
Nivolumab is a human programmed death receptor-1 blocking antibody, used as treatment option in patients with advanced non-small-cell lung cancer (NSCLC). We assessed the nivolumab efficacy terms of survival and response to second-line (2L) or third-line (3L) therapy NSCLC. This multicentric observational study. Data NSCLC who received 2L 3L were analyzed retrospectively. Information regarding patient demographics clinical backgrounds, patterns from diagnosis post-nivolumab treatment,...
In Colombia, paraquat poisoning (PQ) is one of the main causes self-inflicted pesticide poisoning. There not antidotal treatment against its toxicity, influencing an uncertain prognosis and changeful survival. Objective: To describe patients with PQ treated in a high-level hospital to evaluate association mortality clinical laboratory test variables, considering variation over time. Methods: Retrospective study between 2011 2018 at Hospital San Vicente Fundación (Medellín, Colombia)....
Las revisiones sistemáticas de la literatura (RSL) y metaanálisis (MA) son estudios que se encuentran en cima pirámide medicina basada evidencia por su alto poder precisión al combinar los resultados provenientes primarios. Uno problemas más frecuentes es varíen manera significativa entre sí lo conoce como heterogeneidad, puede ser definida variabilidad existe primarios sobre un desenlace, deberse a las diferencias inherentes cada estudio. Se identificar través métodos estadísticos gráficos....
Introducción: El consumo de cocaína se ha incrementado y con ello el número consultas a urgencias hospitalizaciones por intoxicación aguda. objetivo fue describir las características complicaciones los pacientes intoxicados que acudieron al servicio un hospital alta complejidad Colombia.
 Método: estudio corte transversal. Se incluyeron atendidos durante 2016 2019 cocaína, según historia clínica test positivo sin enfermedad base afectara directamente la supervivencia. describieron...
Introduction:The genomic-based 21-gene recurrence score assay (21-GRSA) allows to determine the usefulness of adjuvant chemotherapy in patients with luminal-type early breast cancer (LTEBC).Additional predictive models have also been developed, such as Magee equations (ME), Predict model (PM), and Tennessee nomogram (TNS).Objective: To evaluate concordance between 21-GRSA, ME, PM TNS.Methods: Patients unifocal LTEBC TNS results were included.A subgroup analysis women older than 50 years was...
Introduction: survival outcomes of Non-Small Cell Lung Cancer (NSCLC) reported in the literature may not apply to patients a real-life scenario Colombia. This study aims describe these cohort with NSCLC treated at Clínica de Oncología Astorga, Medellín, Methods: this is an observational analysis. Patients advanced established from January 1/2019 Institution were included. Medical records analyzed retrospectively. Kaplan Meier method was used estimate progression-free (PFS) and overall (OS)....
Objetivos: el nivolumab es un anticuerpo monoclonal contra PD-L1 (programmed death receptor-1) usado como opción terapéutica en pacientes con cáncer de pulmón células no pequeñas (CPCNP) avanzado. Este estudio tuvo objetivo evaluar la experiencia segunda (2L) y tercera línea (3L) tratamiento CPCNP avanzado, diferentes centros oncológicos Colombia.
Introducción: el conocimiento demográfico y de supervivencia del cáncer en Colombia es limitado, sin embargo, intento mejorar este registro está aumento. La Clínica Oncología Astorga un centro tercer nivel que brinda atención especializada Medellín, Colombia. En año 2019 se creó institucional para describir las características sociodemográficas, clínicas, terapéuticas los resultados diez tipos tumores sólidos más frecuentes la institución.
Caso: Paciente masculino en la novena década de vida, con antecedente múltiples neoplasias (cáncer colon y próstata, ambos inactivos), VIH negativo. Se presenta una neoplasia compatible linfoma plasmablástico (LPB) testículo.
Objetivo: La prueba genómica de recurrencia 21 genes (Oncotype DX, Genomic Health) (ODx®) permite determinar la utilidad quimioterapia adyuvante en pacientes con cáncer mama temprano tipo luminal. De forma segura se puede omitir un puntaje riesgo bajo (RB). También han desarrollado otros modelos predictivos basados variables clínicas e histopatológicas estándar. Estos incluyen las ecuaciones Magee (EM), el modelo Predict (MP) y puntuación del nomograma Tennessee (NT). El objetivo este...
The genomic-based 21-gene recurrence score assay (21-GRSA) allows to determine the usefulness of adjuvant chemotherapy in patients with luminal-type early breast cancer (LTEBC). Additional predictive models have also been developed, such as Magee equations (ME), Predict model (PM), and Tennessee nomogram (TNS).To evaluate concordance between 21-GRSA, ME, PM TNS.Patients unifocal LTEBC TNS results were included. A subgroup analysis women older than 50 years was carried out. Concordance...
e21094 Background: Nivolumab is a human programmed death receptor-1 (PD-1) blocking antibody, used as treatment option in patients with advanced non-small cell lung cancer (NSCLC). We assessed the nivolumab efficacy terms of survival and response to second- or third-line therapy NSCLC. Methods: This multicentric observational study. Data NSCLC who received second (2L) (3L) were analyzed retrospectively. Information regarding patient demographics clinical backgrounds, patterns from diagnosis...